SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts RN Tasakis, G Samaras, A Jamison, M Lee, A Paulus, G Whitehouse, ... PloS one 16 (7), e0255169, 2021 | 36 | 2021 |
Interactions among yeast and probiotic bacteria enhance probiotic properties and metabolism offering augmented protection to Artemia franciscana against Vibrio anguillarum V Zoumpourtikoudi, N Pyrgelis, M Chatzigrigoriou, RN Tasakis, M Touraki Microbial pathogenesis 125, 497-506, 2018 | 19 | 2018 |
Harnessing self-labeling enzymes for selective and concurrent A-to-I and C-to-U RNA base editing AS Stroppel, N Latifi, A Hanswillemenke, RN Tasakis, FN Papavasiliou, ... Nucleic acids research 49 (16), e95-e95, 2021 | 13 | 2021 |
MultiEditR: The first tool for detection and quantification of multiple RNA editing sites from Sanger sequencing demonstrates comparable fidelity to RNA-seq M Kluesner, RN Tasakis, T Lerner, A Arnold, S Wüst, M Binder, ... Molecular Therapy-Nucleic Acids, 2021 | 12* | 2021 |
Characterization and Quantitative Determination of a Diverse Group of Bacillus subtilis subsp. subtilis NCIB 3610 Antibacterial Peptides A Karagiota, H Tsitsopoulou, RN Tasakis, V Zoumpourtikoudi, M Touraki Probiotics and Antimicrobial Proteins 13, 555-570, 2021 | 11 | 2021 |
Identification of bacteriocins secreted by the probiotic Lactococcus lactis following microwave-assisted acid hydrolysis (MAAH), amino acid content analysis, and … RN Tasakis, M Touraki Analytical and bioanalytical chemistry 410, 1299-1310, 2018 | 11 | 2018 |
MultiEditR: An easy validation method for detecting and quantifying RNA editing from Sanger sequencing M Kluesner, A Arnold, T Lerner, RN Tasakis, S Wüst, M Binder, ... bioRxiv, 633685, 2019 | 8 | 2019 |
Acute expression of human APOBEC3B in mice results in RNA editing and lethality A Alonso de la Vega, NA Temiz, R Tasakis, K Somogyi, L Salgueiro, ... Genome biology 24 (1), 267, 2023 | 7 | 2023 |
ADAR1-mediated RNA editing promotes B cell lymphomagenesis R Pecori, W Ren, M Pirmoradian, X Wang, D Liu, M Berglund, W Li, ... Iscience 26 (6), 2023 | 7 | 2023 |
ADAR1 can drive Multiple Myeloma progression by acting both as an RNA editor of specific transcripts and as a DNA mutator of their cognate genes RN Tasakis, A Laganà, D Stamkopoulou, DT Melnekoff, P Nedumaran, ... Biorxiv, 2020.02. 11.943845, 2020 | 6 | 2020 |
C-to-U RNA Editing: From Computational Detection to Experimental Validation T Lerner, M Kluesner, RN Tasakis, BS Moriarity, FN Papavasiliou, ... RNA Editing, 51-67, 2021 | 5 | 2021 |
Acute expression of human APOBEC3B in mice causes lethality associated with RNA editing A Alonso de la Vega, NA Temiz, R Tasakis, K Somogyi, E Reuveni, ... BioRxiv, 2022.06. 01.494353, 2022 | 4 | 2022 |
ADAR-Mediated RNA Editing and Its Therapeutic Potentials B Casati, D Stamkopoulou, RN Tasakis, R Pecori Epitranscriptomics, 471, 2021 | 4 | 2021 |
RNA Editors and DNA Mutators: Cancer Heterogeneity Through Sequence Diversification RN Tasakis, FN Papavasiliou, R Shaknovich OBM Genetics 3 (2), 17, 2019 | 2 | 2019 |
RNA-Editing-Initiated MAVS signaling is a key epitranscriptomic alteration in human B cell lymphoma R Pecori, W Ren, X Wang, M Berglund, W Li, RN Tasakis, S Di Giorgio, ... | 1 | 2021 |
Collateral genomic damage due to aberrant RNA editing activity in cancer RN Tasakis | | 2022 |
CYTIDINE DEAMINASES SHAPE THE GENOME OF GERMINAL CENTER B CELL DERIVED LYMPHOMA M Ren, E Sidiropoulou, RN Tasakis, E Donato, I Gonzalez‐Menendez, ... Hematological Oncology 39, 2021 | | 2021 |
ADAR1 Drives Disease Progression in Multiple Myeloma By Acting Both As an RNA Editor of Specific Transcripts and As a DNA Mutator of Their Cognate Genes RN Tasakis, A Lagana, V Leshchenko, D Melnekoff, I Beno, JJ Keats, ... Blood 134, 3092, 2019 | | 2019 |